Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2015-07-07 03:25 | 2015-07-01 | RMD | RESMED INC | FARRELL PETER C | Director, Officer | OPT+S | $55.61 | 36,000 | $2,001,852 | 360,027 |
| 2015-07-07 01:17 | 2015-07-01 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $12.10 | 10,000 | $121,000 | 64,907 |
| 2015-07-02 21:44 | 2015-06-30 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $95.73 | 18,000 | $1,723,117 | 9,354,233 |
| 2015-07-02 00:38 | 2015-06-29 | TTOO | T2 Biosystems, Inc. | Polaris Venture Partners V, L.P. | 10% owner | SELL | $16.09 | 44,997 | $723,930 | 2,258,779 |
| 2015-07-01 01:11 | 2015-06-24 | GKOS | GLAUKOS Corp | MORE ROBERT J | Director | BUY | $18.00 | 5,000 | $90,000 | 5,000 |
| 2015-06-29 23:43 | 2015-06-29 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $97.50 | 6,000 | $584,973 | 9,372,233 |
| 2015-06-27 00:42 | 2015-06-24 | TTOO | T2 Biosystems, Inc. | Polaris Venture Partners V, L.P. | 10% owner | SELL | $17.08 | 44,997 | $768,351 | 2,302,201 |
| 2015-06-26 23:27 | 2015-06-24 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.90 | 18,000 | $1,744,202 | 9,378,233 |
| 2015-06-26 21:36 | 2015-06-24 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $7.33 | 13,205 | $96,781 | 55,746 |
| 2015-06-26 02:10 | 2015-06-23 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | SELL | $77.54 | 5,154 | $399,630 | 81,108 |
| 2015-06-26 02:09 | 2015-06-23 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $77.54 | 5,573 | $432,137 | 179,741 |
| 2015-06-26 02:08 | 2015-06-23 | DXCM | DEXCOM INC | Pacelli Steven Robert | Officer | OPT+S | $77.53 | 14,000 | $1,085,427 | 248,646 |
| 2015-06-25 03:48 | 2015-06-22 | TTOO | T2 Biosystems, Inc. | Polaris Venture Partners V, L.P. | 10% owner | SELL | $18.18 | 29,998 | $545,427 | 2,345,623 |
| 2015-06-24 00:00 | 2015-06-17 | INFU | InfuSystem Holdings, Inc | Meridian OHC Partners, LP | 10% owner | BUY | $3.19 | 7,500 | $23,950 | 2,329,394 |
| 2015-06-23 19:19 | 2015-06-22 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | Officer | OPT+S | $42.51 | 4,902 | $208,394 | 38,188 |
| 2015-06-23 20:18 | 2015-06-22 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $97.44 | 12,000 | $1,169,231 | 9,396,233 |
| 2015-06-22 22:52 | 2015-06-18 | TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Officer | OPT+S | $18.65 | 1,000 | $18,650 | 4,411 |
| 2015-06-22 18:35 | 2015-06-18 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.86 | 12,000 | $1,162,274 | 9,408,233 |
| 2015-06-23 00:47 | 2015-06-22 | ICUI | ICU MEDICAL INC/DE | RIGGS STEVEN | Officer | SELL | $97.00 | 1,110 | $107,670 | 3,115 |
| 2015-06-22 23:19 | 2015-06-18 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $5.78 | 10,000 | $57,782 | 55,746 |
| 2015-06-23 01:20 | 2015-06-18 | DXCM | DEXCOM INC | ROPER JESS | Officer | OPT+S | $77.10 | 7,000 | $539,687 | 107,483 |
| 2015-06-20 00:52 | 2015-06-19 | ICUI | ICU MEDICAL INC/DE | BURCAR ALISON D | Officer | SELL | $97.00 | 9,411 | $912,867 | 0 |
| 2015-06-18 03:56 | 2015-06-15 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $57.87 | 5,975 | $345,791 | 122,440 |
| 2015-06-17 20:03 | 2015-06-15 | INFU | InfuSystem Holdings, Inc | Foster Jonathan P. | Officer | BUY | $3.12 | 312 | $973 | 312 |
| 2015-06-17 20:40 | 2015-06-15 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | Director, Officer | OPT+S | $42.51 | 6,569 | $279,221 | 147,040 |
| 2015-06-17 21:52 | 2015-06-16 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $94.61 | 12,000 | $1,135,272 | 9,420,233 |
| 2015-06-16 22:04 | 2015-06-12 | TTOO | T2 Biosystems, Inc. | Cima Michael J. | Director | BUY | $18.91 | 1,000 | $18,910 | 182,018 |
| 2015-06-16 21:08 | 2015-06-12 | TTOO | T2 Biosystems, Inc. | Lowery Thomas J. | Officer | SELL | $18.55 | 1,471 | $27,287 | 4,411 |
| 2015-06-17 04:05 | 2015-06-15 | DXCM | DEXCOM INC | SKYLER JAY S | Director | SELL | $70.67 | 20,000 | $1,413,426 | 102,771 |
| 2015-06-17 04:03 | 2015-06-15 | DXCM | DEXCOM INC | GREGG TERRANCE H | Director, Officer | SELL | $70.94 | 15,000 | $1,064,141 | 432,139 |
| 2015-06-16 01:08 | 2015-06-15 | INFU | InfuSystem Holdings, Inc | Lehman Gregg Owen | Director | BUY | $3.23 | 2,000 | $6,460 | 20,000 |
| 2015-06-15 22:15 | 2015-06-12 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $95.06 | 12,000 | $1,140,673 | 9,432,233 |
| 2015-06-15 21:21 | 2015-06-11 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $6.29 | 10,000 | $62,883 | 55,746 |
| 2015-06-16 03:13 | 2015-06-11 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | SELL | $73.00 | 9,869 | $720,437 | 86,262 |
| 2015-06-13 00:49 | 2015-06-10 | INFU | InfuSystem Holdings, Inc | Meridian OHC Partners, LP | 10% owner | BUY | $3.16 | 12,786 | $40,425 | 2,321,894 |
| 2015-06-11 19:52 | 2015-05-26 | INFU | InfuSystem Holdings, Inc | Lehman Gregg Owen | Director | BUY | $3.19 | 18,000 | $57,420 | 18,000 |
| 2015-06-11 18:16 | 2015-06-10 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $96.26 | 12,000 | $1,155,146 | 9,444,233 |
| 2015-06-12 00:20 | 2015-06-10 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $43.00 | 6,000 | $258,000 | 19,104 |
| 2015-06-12 01:10 | 2015-06-09 | DXCM | DEXCOM INC | Balo Andrew K | Officer | OPT+S | $70.62 | 7,500 | $529,659 | 179,741 |
| 2015-06-11 23:43 | 2015-06-11 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $96.11 | 16,601 | $1,595,590 | 986,843 |
| 2015-06-11 00:27 | 2015-06-08 | SYK | STRYKER CORP | STRYKER RONDA E | Director | SELL | $94.77 | 12,000 | $1,137,292 | 9,956,233 |
| 2015-06-11 02:05 | 2015-06-10 | ICUI | ICU MEDICAL INC/DE | BURCAR ALISON D | Officer | SELL | $97.00 | 589 | $57,133 | 0 |
| 2015-06-11 03:28 | 2015-06-09 | DXCM | DEXCOM INC | MOY JEFFREY | Officer | SELL | $70.63 | 5,000 | $353,132 | 96,131 |
| 2015-06-11 03:27 | 2015-06-08 | DXCM | DEXCOM INC | LISTER JOHN | Officer | SELL | $72.03 | 1,776 | $127,933 | 127,541 |
| 2015-06-11 03:27 | 2015-06-08 | DXCM | DEXCOM INC | VALDES JORGE A | Officer | OPT+S | $71.32 | 19,680 | $1,403,674 | 6,580 |
| 2015-06-11 00:12 | 2015-06-10 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $96.20 | 20,000 | $1,923,980 | 1,003,444 |
| 2015-06-09 23:45 | 2015-06-05 | LMAT | LEMAITRE VASCULAR INC | Roberts David B | Director, Officer | SELL | $11.17 | 15,000 | $167,613 | 234,839 |
| 2015-06-10 02:12 | 2015-06-09 | ICUI | ICU MEDICAL INC/DE | LOPEZ GEORGE A | Director, 10% owner | SELL | $94.83 | 12,400 | $1,175,855 | 1,023,444 |
| 2015-06-09 00:44 | 2015-06-04 | INFU | InfuSystem Holdings, Inc | DREYER DAVID C | Director | SELL | $3.15 | 10,000 | $31,500 | 130,434 |
| 2015-06-08 20:50 | 2015-06-04 | CTSO | Cytosorbents Corp | Kraus Al | Director | OPT+S | $6.30 | 10,000 | $63,000 | 55,746 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.